The Neonatal Brain Research Group are currently funded for the following research projects among others;
ANSeR: The “Algorithm for Neonatal Seizure Recognition" (ANSeR) project was funded by the Wellcome Trust under a Strategic Translational Award and will fund a study, in hospitals across Europe, to test a computer algorithm that can detect seizures in babies.
NEMO: an EU FP7 funded project entitled "Treatment of neonatal seizures with medication off-patent: Evaluation of efficacy and safety of bumetanide"
HiP: Management of Hypotension In the Preterm Extremely Low Gestational Age Newborn - is an EU FP7 funded project that will be the largest multicentered European study in Extremely Low Gestational Age Newborns (ELGANs).
Babylink: development of a distributed web-based teleneurophysiology application to enable a neurophysiologist interpret, and report on, neonatal EEG promptly from a remote site
NEOPRISM: "Pattern Recognition Systems for Conitnuous Monitoring in Neonates" interpreting the background EEG, which is known as a valuable predictor of outcome and can correctly identify babies who are at high risk of neurological sequelae.
BRANE-Child: The aim of the HRB funded BRANE-Child (Brain Research After Neonatal Encephalopathy) project, is to investigate the predictive validity of neonatal continuous EEG, early developmental assessment, and other markers for five-year outcome in children who have experienced neonatal hypoxic-ischaemic encephalopathy.
SafeBoosC: Safeguarding the brain of our smallest children – an investigator-initiated randomised, blinded, multinational, phase II feasibility clinical trial on near-infrared spectroscopy monitoring combined with defined treatment guidelines versus standard monitoring and treatment as usual in premature infants.
Brain Maturation in Preterm infants: "Automated assessment of brain maturation in the preterm infant using the EEG". This project has been funded to develop an automated algorithm for scoring brain maturational age (BMA) in preterm infants based on the EEG.